April 30, 2019 / 6:26 AM / 2 months ago

BUZZ-India's Sun Pharma falls after U.S. FDA observations on co's Dadra plant

** Sun Pharma’s shares fall nearly 2 pct

** U.S. FDA on Friday issued Form 483 with 11 observations after inspection of co’s Dadra facility during March 22-29

** An FDA Form 483 here is issued to a firm's management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts

** Co says it has submitted its response to the U.S. FDA within the stipulated timeline

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below